2-[({4-Amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl}methyl)amino]-2-[(methylsulfanyl)methyl]propane-1,3-diol

ID: ALA2070402

PubChem CID: 66553591

Max Phase: Preclinical

Molecular Formula: C12H19N5O2S

Molecular Weight: 297.38

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CSCC(CO)(CO)NCc1c[nH]c2c(N)ncnc12

Standard InChI:  InChI=1S/C12H19N5O2S/c1-20-6-12(4-18,5-19)17-3-8-2-14-10-9(8)15-7-16-11(10)13/h2,7,14,17-19H,3-6H2,1H3,(H2,13,15,16)

Standard InChI Key:  GHBSKAVAFUPYHK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   16.6495   -9.9729    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4832   -9.9604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8842   -9.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9110   -7.9072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4129   -8.5649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6904   -8.1779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6730   -9.0002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3754   -9.4246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0956   -9.0278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1091   -8.2023    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4061   -7.7816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4199   -6.9567    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2478  -10.6934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4228  -10.7058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6709  -11.4016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9997   -9.9976    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.1748  -10.0100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6583  -11.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8629  -11.0561    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2692  -12.1222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  9 10  1  0
  4  5  1  0
 10 11  2  0
 11  6  1  0
  5  3  2  0
 11 12  1  0
  2  3  1  0
  1 13  1  0
  3  7  1  0
 13 14  1  0
  6  7  2  0
 13 15  1  0
  1  2  1  0
 14 16  1  0
  7  8  1  0
 16 17  1  0
 13 18  1  0
  8  9  2  0
 18 19  1  0
  6  4  1  0
 15 20  1  0
M  END

Associated Targets(Human)

MTAP Tchem S-methyl-5-thioadenosine phosphorylase (233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 297.38Molecular Weight (Monoisotopic): 297.1259AlogP: -0.28#Rotatable Bonds: 7
Polar Surface Area: 120.08Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.46CX Basic pKa: 8.11CX LogP: -0.75CX LogD: -1.53
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.48Np Likeness Score: -0.27

References

1. Clinch K, Evans GB, Fröhlich RF, Gulab SA, Gutierrez JA, Mason JM, Schramm VL, Tyler PC, Woolhouse AD..  (2012)  Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.,  20  (17): [PMID:22854195] [10.1016/j.bmc.2012.07.006]
2. Longshaw, Alistair I and 5 more authors.  2010-09-23  Design and synthesis of potent "sulfur-free" transition state analogue inhibitors of 5'-methylthioadenosine nucleosidase and 5'-methylthioadenosine phosphorylase.  [PMID:20718423]
3. Clinch, Keith and 8 more authors.  2012-09-01  Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.  [PMID:22854195]
4. Evans, Gary B and 7 more authors.  2015-09-01  Tight binding enantiomers of pre-clinical drug candidates.  [PMID:26260335]
5. Harijan, Rajesh K and 7 more authors.  2019-04-11  Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase.  [PMID:30860833]

Source